Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,425 | -49,132 | -28,980 | 17,378 | -75,367 |
| Depreciation Amortization | 117 | 87 | 58 | 29 | 114 |
| Accounts receivable | -1,491 | -1,751 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,666 | 1,636 | -406 | 4,224 | 1,394 |
| Other Working Capital | 4,859 | 3,152 | 967 | 6,889 | -3,018 |
| Other Operating Activity | 5,444 | 6,556 | 810 | -39,487 | 8,083 |
| Operating Cash Flow | $-51,829 | $-39,452 | $-27,551 | $-10,967 | $-68,794 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 33,100 | 33,100 | 33,100 | N/A | N/A |
| Debt Repayment | -36,143 | -33,817 | -32,910 | N/A | -4 |
| Common Stock Issued | 48,028 | 34,143 | 19,990 | 1,742 | 60,334 |
| Financing Cash Flow | $44,985 | $33,426 | $20,180 | $1,742 | $60,329 |
| Beginning Cash Position | 14,928 | 14,928 | 14,928 | 14,928 | 23,392 |
| End Cash Position | 8,083 | 8,901 | 7,556 | 5,703 | 14,928 |
| Net Cash Flow | $-6,845 | $-6,027 | $-7,371 | $-9,225 | $-8,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,829 | -39,452 | -27,551 | -10,967 | -68,794 |
| Free Cash Flow | -51,829 | -39,452 | -27,551 | -10,967 | -68,794 |